Open AccessAn observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice
Author(s) -
K. M. Nyushko,
B. Ya. Alekseev,
В. М. Перепухов,
И. М. Шевчук,
В. А. Атдуев,
А. B. Zdobnikov,
V. B. Venskel,
Eduard Gurin,
A. V. Eremenko,
I. V. Belov,
V. D. Gavrilova,
R. M. Ismakov,
Д. Г. Прохоров,
R. V. Nikitin,
Е. А. Усынин,
E. I. Kopyltsov,
О. В. Леонов,
А. О. Леонова
Publication year - 2022
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2022-18-2-102-110
Subject(s) - medicine , prostate cancer , docetaxel , enzalutamide , prostatectomy , radiation therapy , oncology , hormone therapy , observational study , urology , cancer , breast cancer , androgen receptor